You are right, CD15 was the old longhauler trial.*
Post# of 148112
Do we already know what the new longhauler trial will be named? CD18 or CD19?
It is a little bit strange that the FDA needs so much time for the release of the new longhauler trial (CD15 results were presented to shareholders in june). If they really aim for a trial start in January, they will need a confirmation from FDA in December ...
I do not hope FDA is deliberately delaying us until one of their BP protégés submits a longhauler trial too.